Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large ...

Moderna ( MRNA 1.03%) has been on fire this year. As of this writing, the company's shares have slightly more than doubled to ...

The viral type 2 internal ribosome entry site uses a unique mechanism to hijack the host ribosomal machinery by interacting with initiator tRNA and 40S head.

The FDA’s Vaccines and Related Biological Products Advisory Committee has unanimously backed Moderna’s mRNA-based flu shot, ...

Sen. Elizabeth Warren clashed with a witness during a heated Senate hearing over Donald Trump’s proposal to cap credit card ...

Moderna received a unanimous advisory committee vote supporting mRNA-1010, its flu vaccine, for adults 50 and older. Read ...

Researchers have identified "DNA switches" that become active as honeybee larvae grow into worker bees, offering new insight ...

The iShares Morningstar Small-Cap Value ETF (ISCV) carries a lower expense ratio of 0.06% compared to 0.24% for the iShares Russell 2000 Value ETF (IWN). ISCV's 1.88% dividend yield is higher than IWN ...

Western Digital topped the list, rising 32.61%, and it’s up 126.98% over the past three months. This no-moat company with a 1 ...

We have curated a list of in vivo CAR T biotech companies in preclinical and clinical stages that you should keep an eye out ...

Moderna flu vaccine faces a key FDA advisory panel review as analysts weigh approval odds, postmarketing study costs, and ...